Lazard Asset Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,210
| Closed | -$23K | – | 2361 |
|
|
2023
Q2 | $23K | Buy |
+4,210
| New | +$23K | ﹤0.01% | 2075 |
|
|
2022
Q4 | – | Sell |
-7,120
| Closed | -$18K | – | 2460 |
|
|
2022
Q3 | $18K | Sell |
7,120
-4,869
| -41% | -$12.3K | ﹤0.01% | 2101 |
|
|
2022
Q2 | $43K | Buy |
11,989
+4,869
| +68% | +$17.5K | ﹤0.01% | 1880 |
|
|
2022
Q1 | $44K | Buy |
7,120
+4,966
| +231% | +$30.7K | ﹤0.01% | 1807 |
|
|
2021
Q4 | $15K | Hold |
2,154
| – | – | ﹤0.01% | 2091 |
|
|
2021
Q3 | $15K | Hold |
2,154
| – | – | ﹤0.01% | 2050 |
|
|
2021
Q2 | $17K | Buy |
+2,154
| New | +$17K | ﹤0.01% | 1867 |
|